Biotechnology firms are leveraging decentralized clinical trial software to mitigate historic delay factors in drug development. Algorithmic matching tools are speeding up cohort selection while maintaining compliance standards.
Data Real-Time Ingestion
Continuous monitoring via medical-grade wearables allows research teams to capture primary endpoints remotely. The resulting reduction in site visit requirements has boosted participant retention and improved statistical power in preliminary efficacy studies.